1.
Woo H, Jang Y, Kim S, Kim W, Zhang F, Mall R, et al. Pharmacological Targeting of the NLRP3 trLRR Domain with Isothiazolinones Overcomes CRID3-Resistant Inflammation [Internet]. LangTaoSha Preprint Server. 2026 [cited 2026 Feb. 4]. Available from: https://langtaosha.org.cn/index.php/lts/preprint/view/113